Roger KC Ngan

Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

Anthony T.�C. Chan, S. F. Leung, Roger KC Ngan et al. · JNCI Journal of the National Cancer Institute · 2005 · 521 citations

Medicine, Oncology, Radiation Oncology +13

Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.

Michael M.H. Cheung, John K. C. Chan, W.H. Lau et al. · Journal of Clinical Oncology · 1998 · 451 citations

Medicine, Oncology, Otolaryngology +14

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality

Michael M.C. Cheung, John K. C. Chan, Wai‐Hon Lau et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 279 citations

Medicine, Oncology, Otolaryngology +14

Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial

Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong et al. · Annals of Oncology · 2022 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease.

Roger KC Ngan, Timothy T.C. Yip, Wai-Wai Cheng et al. · PubMed · 2002 · 85 citations

Life Sciences, Immunology, Oncology +16